Fulgent Genetics, Inc.
FLGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.8% | 11.4% | -3.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 42.2% | 42.1% | 38.6% | 41.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0.1% | -18.9% | -7.9% | -13% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7.9% | -23.2% | -15.7% | -7.7% |
| EPS Diluted | -0.21 | -0.61 | -0.37 | -0.19 |
| % Growth | 65.6% | -64.9% | -94.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |